Alabama settles for $276M with McKesson, J&J and Endo over opioid crisis
Alabama’s attorney general stood by his decision to not participate in the national opioid settlements, announcing Tuesday that the state has reached deals with Johnson & Johnson, Endo Pharmaceuticals and McKesson for about $276 million to resolve the state’s claims against them for exacerbating the opioid crisis.
J&J will pay about $70 million in a lump-sum payment, which is the same amount as what Alabama would’ve received in a national settlement, but it’ll be paid out in one year instead of 9 years, the AG said. J&J also recently agreed to pay West Virginia $99 million as part of another opioid-related settlement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
